5ACL
Mcg immunoglobulin variable domain with sulfasalazine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 24-ID-C |
Synchrotron site | APS |
Beamline | 24-ID-C |
Temperature [K] | 100 |
Collection date | 2015-03-09 |
Detector | RIGAKU HCT |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 31.860, 74.610, 39.280 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 29.320 - 1.490 |
R-factor | 0.1597 |
Rwork | 0.158 |
R-free | 0.18742 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4unu |
RMSD bond length | 0.023 |
RMSD bond angle | 2.037 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0107) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 100.000 | 1.530 |
High resolution limit [Å] | 1.500 | 1.500 |
Rmerge | 0.050 | 0.530 |
Number of reflections | 15567 | |
<I/σ(I)> | 19 | 4 |
Completeness [%] | 98.0 | 83 |
Redundancy | 6.8 | 6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | 0.2 M TRI-POTASSIUM CITRATE, 2.2 M (NH4)2SO4, 0.5 M SULFASALAZINE, pH 8.5 |